Ra Medical Systems, Inc. (RMED)
After hours:
- Business Wire
Ra Medical Systems Reports First Quarter 2022 Financial Results
CARLSBAD, Calif., May 16, 2022--Ra Medical Systems, Inc. (NYSE American: RMED) ("Ra Medical" or "the Company"), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months ended March 31, 2022 and provides a business update.
- Business Wire
Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022
CARLSBAD, Calif., May 09, 2022--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.
- Business Wire
Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area
CARLSBAD, Calif., April 05, 2022--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent 11,284,941 (the ’941 patent), titled Laser Ablation Catheters Having Expanded Distal Tip Windows for Efficient Tissue Ablation, describ
